Remicade approved for early arthritis treatment in Australia

03/29/2006 | Australian (tiered subscription model), The

Australia's Therapeutic Goods Administration has approved Remicade for early treatment of rheumatoid arthritis, a disease affecting more than 450,000 people in the country. Until now, Remicade was available to patients only after three years of other treatments, by which time patients often suffered significant joint damage.

View Full Article in:

Australian (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ